NCT07085273 2025-07-31Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric CancerThe First Affiliated Hospital of Zhengzhou UniversityPhase 2 Not yet recruiting33 enrolled